Investors

Announcements

2022

Appointment of Director & Grant of Options

04 June 2021

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the spinal (vertebral) stabilisation market announces the appointment of Mr. Nikunj (Nik) Kantilal Patel as Non-Executive Director of the Company with immediate effect.

Nik has been a practising Consultant Neurosurgeon and Honorary Senior Clinical Lecturer at the Institute of Clinical Neurosciences (University of Bristol) since his appointment in 2005, where he has developed specialist interests and expertise in surgical treatments for spinal pain, cranial nerve hyperactive disorders and functional brain disorders. His surgical and research interests have focused on developing innovations, and advancing less-invasive and stream-lined procedural solutions. He has been recognised for his neurosurgical research excellence with a Medical Research Council fellowship; awards from both the American and the European Associations of Neurological Surgeons; and a Hunterian Professorship from the Royal College of Surgeons of England.

 

Grant of Options

Simultaneous with the appointment of Nik Patel to the Board, the Company has awarded 250,000 options over new ordinary shares (the "Options") to Nik Patel on 4 June 2021. The Options are exercisable at a price of 36 pence per share, vest immediately and expire on 4 June 2024.

Other than as set out below, there are no other matters required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Apex Rulebook as regards Mr. Nikunj Kantilal Patel's appointment.

 

Current Directorships

Directorships in the past 5 years

Bioinduction Limited

None

Nik Patel Limited

 

Ranvier Health Limited

 

Suzie Limited (Guernsey)

 

 

Mr. Nikunj Kantilal Patel (aged 50) holds 16,667 ordinary shares and 250,000 options over new ordinary shares in the Company (as described above).

Ian Roberts, CEO, commented: "The Board and I are delighted to welcome Nik to the Company at this exciting stage of its development."

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

Enquiries:

Truspine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 

 

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 

 

 

WH Ireland (Broker)

Tel: +44 (0)20 7220 1666

Adam Pollock

 

 

 

Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Nik Patel

2

Reason for notification

 

a.

Position/Status

Non-Executive Director

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

TruSpine Technologies PLC

b.

LEI

213800HNZX9B1QZPB225

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument


Identification Code

Options over ordinary shares of 0.01 pence
 

ISIN: GB00BMZCKL55

b.

Nature of the transaction

Grant of options

 

c.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s) per share

Volume(s)

 

36p

250,000

 

 

 

d.

Aggregated information

-       Volume

-       Price

 

n/a

e.

Date of the transaction

4 June 2021

f.

Place of the transaction

AQSE APX Market

 

2021

Appointment of Director & Grant of Options

04 June 2021

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the spinal (vertebral) stabilisation market announces the appointment of Mr. Nikunj (Nik) Kantilal Patel as Non-Executive Director of the Company with immediate effect.

Nik has been a practising Consultant Neurosurgeon and Honorary Senior Clinical Lecturer at the Institute of Clinical Neurosciences (University of Bristol) since his appointment in 2005, where he has developed specialist interests and expertise in surgical treatments for spinal pain, cranial nerve hyperactive disorders and functional brain disorders. His surgical and research interests have focused on developing innovations, and advancing less-invasive and stream-lined procedural solutions. He has been recognised for his neurosurgical research excellence with a Medical Research Council fellowship; awards from both the American and the European Associations of Neurological Surgeons; and a Hunterian Professorship from the Royal College of Surgeons of England.

 

Grant of Options

Simultaneous with the appointment of Nik Patel to the Board, the Company has awarded 250,000 options over new ordinary shares (the "Options") to Nik Patel on 4 June 2021. The Options are exercisable at a price of 36 pence per share, vest immediately and expire on 4 June 2024.

Other than as set out below, there are no other matters required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Apex Rulebook as regards Mr. Nikunj Kantilal Patel's appointment.

 

Current Directorships

Directorships in the past 5 years

Bioinduction Limited

None

Nik Patel Limited

 

Ranvier Health Limited

 

Suzie Limited (Guernsey)

 

 

Mr. Nikunj Kantilal Patel (aged 50) holds 16,667 ordinary shares and 250,000 options over new ordinary shares in the Company (as described above).

Ian Roberts, CEO, commented: "The Board and I are delighted to welcome Nik to the Company at this exciting stage of its development."

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

Enquiries:

Truspine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 

 

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 

 

 

WH Ireland (Broker)

Tel: +44 (0)20 7220 1666

Adam Pollock

 

 

 

Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Nik Patel

2

Reason for notification

 

a.

Position/Status

Non-Executive Director

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

TruSpine Technologies PLC

b.

LEI

213800HNZX9B1QZPB225

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument


Identification Code

Options over ordinary shares of 0.01 pence
 

ISIN: GB00BMZCKL55

b.

Nature of the transaction

Grant of options

 

c.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s) per share

Volume(s)

 

36p

250,000

 

 

 

d.

Aggregated information

-       Volume

-       Price

 

n/a

e.

Date of the transaction

4 June 2021

f.

Place of the transaction

AQSE APX Market

 

2020

Appointment of Director & Grant of Options

04 June 2021

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the spinal (vertebral) stabilisation market announces the appointment of Mr. Nikunj (Nik) Kantilal Patel as Non-Executive Director of the Company with immediate effect.

Nik has been a practising Consultant Neurosurgeon and Honorary Senior Clinical Lecturer at the Institute of Clinical Neurosciences (University of Bristol) since his appointment in 2005, where he has developed specialist interests and expertise in surgical treatments for spinal pain, cranial nerve hyperactive disorders and functional brain disorders. His surgical and research interests have focused on developing innovations, and advancing less-invasive and stream-lined procedural solutions. He has been recognised for his neurosurgical research excellence with a Medical Research Council fellowship; awards from both the American and the European Associations of Neurological Surgeons; and a Hunterian Professorship from the Royal College of Surgeons of England.

 

Grant of Options

Simultaneous with the appointment of Nik Patel to the Board, the Company has awarded 250,000 options over new ordinary shares (the "Options") to Nik Patel on 4 June 2021. The Options are exercisable at a price of 36 pence per share, vest immediately and expire on 4 June 2024.

Other than as set out below, there are no other matters required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Apex Rulebook as regards Mr. Nikunj Kantilal Patel's appointment.

 

Current Directorships

Directorships in the past 5 years

Bioinduction Limited

None

Nik Patel Limited

 

Ranvier Health Limited

 

Suzie Limited (Guernsey)

 

 

Mr. Nikunj Kantilal Patel (aged 50) holds 16,667 ordinary shares and 250,000 options over new ordinary shares in the Company (as described above).

Ian Roberts, CEO, commented: "The Board and I are delighted to welcome Nik to the Company at this exciting stage of its development."

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

Enquiries:

Truspine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 

 

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 

 

 

WH Ireland (Broker)

Tel: +44 (0)20 7220 1666

Adam Pollock

 

 

 

Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Nik Patel

2

Reason for notification

 

a.

Position/Status

Non-Executive Director

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

TruSpine Technologies PLC

b.

LEI

213800HNZX9B1QZPB225

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument


Identification Code

Options over ordinary shares of 0.01 pence
 

ISIN: GB00BMZCKL55

b.

Nature of the transaction

Grant of options

 

c.

Price(s) and volume(s)

 

 

 

 

 

 

Price(s) per share

Volume(s)

 

36p

250,000

 

 

 

d.

Aggregated information

-       Volume

-       Price

 

n/a

e.

Date of the transaction

4 June 2021

f.

Place of the transaction

AQSE APX Market